Vimarsana.com

Latest Breaking News On - Acasti pharma daily - Page 1 : vimarsana.com

Acasti Pharma (NASDAQ:ACST) Stock Passes Below 200-Day Moving Average of $2.79

Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report) passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $2.79 and traded as low as $2.63. Acasti Pharma shares last traded at $2.72, with a volume of 13,600 shares traded. Wall Street Analyst […]

Canada
Acasti-pharma
Craig-hallum
Acasti-pharma-inc
Nasdaq
Get-free-report
Pharma-inc
Acasti-pharma-daily

Acasti Pharma (NASDAQ:ACST) Stock Crosses Above Two Hundred Day Moving Average of $2.77

Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.77 and traded as high as $2.80. Acasti Pharma shares last traded at $2.70, with a volume of 15,108 shares. Analyst Upgrades and Downgrades Separately, Craig […]

Canada
Craig-hallum
Acasti-pharma
Acasti-pharma-inc
Nasdaq
Get-free-report
Pharma-trading-down
Pharma-inc
Acasti-pharma-daily

Acasti Pharma (NASDAQ:ACST) Stock Passes Above Two Hundred Day Moving Average of $2.75

Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.75 and traded as high as $3.08. Acasti Pharma shares last traded at $2.96, with a volume of 13,180 shares trading hands. Analyst Ratings Changes Separately, Craig […]

Canada
Craig-hallum
Acasti-pharma
Nasdaq
Acasti-pharma-inc
Get-free-report
Pharma-stock-down
Pharma-inc
Acasti-pharma-daily
Nasdaq-acst
Acst
Medical

Short Interest in Acasti Pharma Inc. (NASDAQ:ACST) Expands By 171.4%

Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report) saw a large increase in short interest in April. As of April 15th, there was short interest totalling 3,800 shares, an increase of 171.4% from the March 31st total of 1,400 shares. Approximately 0.1% of the company’s shares are sold short. Based on an average trading volume […]

Canada
Acasti-pharma
Craig-hallum
Nasdaq
Acasti-pharma-company-profile
Acasti-pharma-inc
Get-free-report
Pharma-inc
Acasti-pharma-daily
Nasdaq-acst
Acst
Medical

Acasti Pharma (NASDAQ:ACST) Stock Crosses Above 200-Day Moving Average of $2.65

Shares of Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.65 and traded as high as $3.41. Acasti Pharma shares last traded at $3.38, with a volume of 34,601 shares traded. Wall Street Analysts Forecast Growth […]

Canada
United-states
America
Craig-hallum
Acasti-pharma
Royal-bank
America-corp
Capital-management
Acasti-pharma-company-profile
Renaissance-technologies
Acasti-pharma-inc
Nasdaq

Acasti Pharma (NASDAQ:ACST) Stock Passes Above Two Hundred Day Moving Average of $2.65

Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.65 and traded as high as $3.41. Acasti Pharma shares last traded at $3.38, with a volume of 34,601 shares. Analyst Ratings Changes Separately, Craig Hallum […]

United-states
Canada
America
Craig-hallum
Acasti-pharma
Renaissance-technologies
Capital-management
America-corp
Acasti-pharma-inc
Nasdaq
Royal-bank
Get-free-report

Acasti Pharma Inc. (NASDAQ:ACST) Short Interest Up 20.4% in January

Acasti Pharma Inc. (NASDAQ:ACST) Short Interest Up 20.4% in January
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
America
Craig-hallum
Acasti-pharma
Acasti-pharma-company-profile
Capital-management
Acasti-pharma-inc
America-corp
Nasdaq
Renaissance-technologies
Royal-bank

Acasti Pharma (NASDAQ:ACST) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Acasti Pharma (NASDAQ:ACST – Get Free Report) released its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.02, MarketWatch Earnings reports. Acasti Pharma Stock Down 6.1 % Shares of Acasti Pharma stock opened at $2.45 on Wednesday. Acasti Pharma has a 1 […]

Canada
Acasti-pharma
Craig-hallum
Acasti-pharma-inc
Nasdaq
Renaissance-technologies
Acasti-pharma-company-profile
Get-free-report
Marketwatch-earnings
Pharma-stock-down
Free-report
Pharma-inc

Acasti Pharma (NASDAQ:ACST) Issues Earnings Results, Beats Expectations By $0.02 EPS

Acasti Pharma (NASDAQ:ACST) Issues Earnings Results, Beats Expectations By $0.02 EPS
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Canada
Craig-hallum
Acasti-pharma
Renaissance-technologies
Acasti-pharma-company-profile
Acasti-pharma-inc
Exchange-commission
Nasdaq
Get-free-report
Marketwatch-earnings
Pharma-stock-down
Free-report

Acasti Pharma (NASDAQ:ACST) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Acasti Pharma (NASDAQ:ACST) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPS
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Canada
Craig-hallum
Acasti-pharma
Nasdaq
Exchange-commission
Acasti-pharma-inc
Renaissance-technologies
Get-free-report
Marketwatch-earnings
Free-report
Pharma-inc
Acasti-pharma-daily

vimarsana © 2020. All Rights Reserved.